Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Citizens analysts reiterated a Market Outperform rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on August 04, 2026. Market Context aTyr Pharma, Inc.
Read moreRating Change UBS analysts reiterated a Buy rating on Generac Holdings Inc. (NYSE:GNRC) on August 04, 2026. Market Context Generac Holdings Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex…
Read moreRating Change Canaccord Genuity analysts reiterated a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on August 04, 2026. Market Context Vertex Pharmaceuticals Incorporated…
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Welltower Inc. (NYSE:WELL) on August 04, 2026. Market Context Welltower Inc.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Palo Alto Networks, Inc. (NASDAQ:PANW) on August 04, 2026. Market Context Palo Alto Networks, Inc.
Read moreRating Change Argus Research analysts reiterated a Buy rating on KKR & Co. Inc. (NYSE:KKR) on August 04, 2026.
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on The Progressive Corporation (NYSE:PGR) on August 04, 2026. Market Context The Progressive Corporation operates in…
Read moreRating Change Freedom Broker analysts upgraded Exxon Mobil Corporation (NYSE:XOM) from Sell to Hold on August 04, 2026. Market Context Exxon Mobil Corporation operates in the…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on FibroBiologics, Inc. Common Stock (NASDAQ:FBLG) on August 04, 2026.
Read moreRating Change Benchmark analysts initiated coverage on Maywood Acquisition Corp. Unit (NASDAQ:MAYAU) with a Buy rating on August 04, 2026. Market Context Maywood Acquisition Corp.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on 5E Advanced Materials Inc. (NASDAQ:FEAM) on August 04, 2026.
Read moreRating Change Benchmark analysts initiated coverage on Inflection Point Acquisition Corp. V (NASDAQ:IPEXU) with a Buy rating on August 04, 2026. Market Context Inflection Point…
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on MFA Financial, Inc. (NYSE:MFA) on August 04, 2026. Market Context MFA Financial, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on EverQuote, Inc. (NASDAQ:EVER) on August 04, 2026. Market Context EverQuote, Inc.
Read moreRating Change B. Riley Securities analysts reiterated a Buy rating on EverQuote, Inc. (NASDAQ:EVER) on August 04, 2026.
Read moreRating Change BMO Capital analysts reiterated a Market Perform rating on Easterly Government Properties, Inc. (NYSE:DEA) on August 04, 2026. Market Context Easterly Government…
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Ameresco, Inc. (NYSE:AMRC) on August 04, 2026. Market Context Ameresco, Inc.
Read more
